[A study on the retreatment of pulmonary tuberculosis by the addition of 654-2].
654-2 plus chemotherapy were used to retreat TB. After a full course of treatment, rates of negative sputum in the observation group and in the control group were 90.6% and 68.8% respectively (The difference in the rates was statistically significant P less than 0.05). The total rate of focus in the observation group was 46.9% and that in the control group was 21.9%. The difference was striking (P less than 0.05). The general efficacy for cavity alteration in the observation group was 42.3% and in control group was 16.0%. Comparing the two groups, there was an obvious difference (P less than 0.05). After ceasing medication, no relapse was observed through a period of one year in the treated group.
Li
Z C
ZC
D000293:Adolescent; D000328:Adult; D000368:Aged; D000995:Antitubercular Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012991:Solanaceous Alkaloids / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D012991:Solanaceous Alkaloids; C003922:anisodamine